New findings on the support and barriers to combat TB in high-burden countries
Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme. The managers of these programmes agree that it is important to screen for tuberculosis outside of health facilities. However, each screening programme must have its own well-considered, sustainable strategy and sufficient resources for it to be meaningful - which is not always the case today. This is one conclusion drawn by Olivia Biermann s forthcoming thesis.
At a global level, tuberculosis (TB) is still one of the deadliest infection diseases, affecting an estimated 10 million people every year, primarily people living in poverty in low and middle-income countries. Roughly 90 percent of cases occur in 30 identified countries, including India, Vietnam and South Africa. However, nearly a third of those infected - 2.9 million people - receive neither a diagno
A tragic blow for ‘Global Britain’ and the world’s most vulnerable people
Neglected Tropical Diseases like blinding trachoma, intestinal worms, and elephantiasis affect 1.7 billion people around the world | Copyright: Uniting to Combat Neglected Tropical Diseases / Marcus Perkins. Uniting to Combat NTDs
One billion young people are affected by Neglected Tropical Diseases. Yet the UK Government has withdrawn funding from programmes that support these communities. What happened to the idea of ‘Global Britain’?
The UK Government has unilaterally withdrawn over £150M to programmes that protect the most vulnerable children and adults from debilitating, disabling, and killing diseases called neglected tropical diseases (NTDs), and to research and development in NTDs.
Annette Kennedy is the President of the International Council of Nurses.
As a Registered Nurse Tutor at Beaumont Hospital, she established the first neuro-ICU in Ireland. She also set up many of the hospital’s post-registration specialist training programmes for nurses.
In 1993, Annette took up the post of Director of Professional Development with the Irish Nurses and Midwives Organisation (INMO).
Having proven her leadership at national level, in 2005 Annette became the President of the European Federation of Nurses, representing nursing professionals in 30 countries.
In June 2017, Annette was elected 28th President of the International Council of Nurses, following a four year term as Vice President of the organisation.
BBC News
By Michelle Roberts
Published
image copyrightGetty Images
image captionOver-50s who have had a dose of the Pfizer or AstraZeneca vaccine can take part in a study on mixing jabs
A major UK trial looking at whether Covid vaccines can be mixed with different types of jabs used for first and second doses is being expanded.
Combining vaccines might give broader, longer-lasting immunity against the virus and new variants of it, and offer more flexibility to vaccine rollout.
Adults over 50 who have had a first dose of Pfizer or AstraZeneca can apply to take part in the Com-Cov study.
London - A major United Kingdom trial looking at whether coronavirus (COVID-19) vaccines can be mixed with different types of jabs used for first and second doses is being expanded. Combining vaccines might give broader, longer-lasting immunity against the virus and new variants of it, and offer more flexibility to vaccine rollout. Adults over 50 who have had a first dose of Pfizer or AstraZeneca can apply to take part …